PLSEPulse Biosciences, Inc.
47.79USD+1.64%Mkt Cap: 3.35B $P/E:

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers nPulse System, a novel Nanosecond Pulsed-Field Ablation delivery platform to treat benign lesions of the skin; nPulse Vybrance Percutane…

Key Statistics

Company
Market Cap3.35B $
Enterprise Value3.32B $
Revenue (TTM)1.19M $
Gross Profit-189.00K $
Net Income (TTM)-72.78M $
Revenue/Share0.0170 USD
Last Price47.79 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees116
CountryUS
SectorHealthcare
IndustryMedical Instruments & Supplies
ISINUS74587B1017
Valuation
P/E (Trailing)
P/E (Forward)-41.43
PEG
EV/EBITDA-40.16
EV/Revenue2799.95
P/S2879.99
P/B34.06
EPS (TTM)-1.19
EPS (Forward)-1.16
52W Range
12.5697% of range48.84
52W High48.84 USD
52W Low12.56 USD
Profitability
Gross Margin-54.00%
Oper. Margin-5823.04%
EBITDA Margin0.00%
Profit Margin-20794.57%
ROE-90.24%
ROA-76.99%
Growth
Revenue Growth
Earnings Growth
Cash Flow & Leverage
Operating CF-54.12M $
CapEx (TTM)335.00K $
FCF Margin-2893.27%
FCF Yield-1.02%
Net Debt-94.85M $
Net Debt/EBITDA1.15
Balance Sheet
Debt/Equity0.09
Current Ratio9.63
Quick Ratio9.27
Book Value/Sh1.405 USD
Cash/Share1.425 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Analyst Consensus
Rating1.3 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)45.25 USD
Upside (mean)-5.3%
Target Range35.00 USD58.00 USD
$35.00-5.3% to mean$58.00
# Analysts4
Ownership
Shares Out.71.32M
Float20.59M
Insiders71.04%
Institutions15.38%
Short Interest
Short Ratio8.6d
Short % Float13.99%
Short % Out.4.18%
Shares Short2.98M
Short (prev mo.)2.86M
Technical
SMA 5032.51 (+47.0%)
SMA 20022.14 (+115.8%)
Beta1.58
S&P 52W Chg18.16%
Avg Vol (30d)403.24K
Avg Vol (10d)497.29K
Technical Indicators
RSI (14)78.1
MACD4.4678
MACD Signal3.8150
MACD Hist.+0.6528
BB Upper49.37 USD
BB Middle38.68 USD
BB Lower27.99 USD
BB Width55.26%
ATR (14)2.867 USD
Vol Ratio (20d)0.91x